Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates
- Akoya Biosciences reported $0.35 loss per share, missing estimates by 16.67%. - Revenues for Akoya were $18.35 million, below estimates by 23.94%. - Akoya shares have decreased by 12.6% this year compared to S&P 500's gain of 9.5%. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
View signal analysis